US Stock MarketDetailed Quotes

RXRX Recursion Pharmaceuticals

Watchlist

8.340
+0.200+2.46%

Close Feb 26 16:00 ET

8.250
-0.090-1.08%

Post 19:59 ET

3.26BMarket Cap-5.42P/E (TTM)

Recursion Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Recursion Pharmaceuticals Q4 2024 Estimates Date

Currency：USDFeb 28, 2025

	Estimate	YoY
Revenue	19.04M	+74.85%
EPS	-0.46	-8.76%

Analyst Rating

Buy

Feb 6, 2025

Recursion Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 12.000M	--
Feb 28, 2025	2024/Q4	-- / 19.043M	--
Nov 6, 2024	2024/Q3	26.082M / 29.829M	--
Aug 8, 2024	2024/Q2	14.417M / 13.286M	--
May 9, 2024	2024/Q1	13.794M / 13.067M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 12.000M--

Feb 28, 20252024/Q4-- / 19.043M--

Nov 6, 20242024/Q326.082M / 29.829M--

Aug 8, 20242024/Q214.417M / 13.286M--

May 9, 20242024/Q113.794M / 13.067M--

Unlock Free Earnings Estimates

Open Account

Recursion Pharmaceuticals Earnings Reports

Recursion Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 6, 2024 16:23 ET

Recursion Pharmaceuticals | 8-K: Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results